Dose finding and constipation effect by the intake of a newly oligomeric condensation of lactic acids, GL-1708: a randomized, double blind, placebo-controlled study - Dose finding and constipation effect by the intake of a newly oligomeric condensation of lactic acids, LAC

Kands R&D Corporation0 个研究点目标入组 60 人开始时间: 2018年4月30日最近更新: 2023年10月17日

试验速览

This study aims to evaluate the effects of ingestion of food containing LAC for 4 weeks on constipation effect in subjects with bowel movement lower

•1) A medical history of severe disorders, which affects absorption, metabolism, excretion in the digestive tract, heart, liver, thyroid gland and kidney, or those subjects who have difficulty in participating in this study of their past medical history 2) Gastrectomy, gastrointestinal sutures, who have major surgery history affects absorption in the gastrointestinal tract site such as intestinal resection 3) Those who have hypersensitivity to drugs or idiosyncrasies 4) Those who have ever suffered from a physical disorder by ingesting a commercially available supplement 5) Alcohol or drug addicts 6) Pregnancy or women of childbearing potential, who wish to become pregnant during lactation or test period 7) Those who are participating in other clinical trials at the start of this study 8) Those who participated in clinical trials of medicines within 16 weeks before this study, or human examination of health food within 8 weeks 9) Those who took medical prescription medicines such as an intestinal tract or the like, which have an effect on constipation treatment etc. within one week before the start of the study 10) Those who collected 400 mL or more of whole blood within 12 weeks before the start of the test 11) In addition, those judged unsuitable as subjects by investigators

发起方

Kands R&D Corporation